Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties-Reference-Cited by-同舟云学术

Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties

Published:2012-10 Issue:20 Volume:20 Page:6063-6072
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Rakesh ,Bruhn David,Madhura Dora B.,Maddox Marcus,Lee Robin B.,Trivedi Ashit,Yang Lei,Scherman Michael S.,Gilliland Janet C.,Gruppo Veronica,McNeil Michael R.,Lenaerts Anne J.,Meibohm Bernd,Lee Richard E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference28 articles.

1. Testing for the equality of area under the curves when using destructive measurement techniques

2. Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

3. PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release

4. Discovery of novel isoxazolines as anti-tuberculosis agents

5. Synthesis and Evaluation of Cyclic Secondary Amine Substituted Phenyl and Benzyl Nitrofuranyl Amides as Novel Antituberculosis Agents

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway;Journal of Medicinal Chemistry;2023-12-29

2. Nitrile Oxide, Alkenes, Dipolar Cycloaddition, Isomerization and Metathesis Involved in the Syntheses of 2-Isoxazolines;Molecules;2023-03-10

3. The piperazine scaffold for novel drug discovery efforts: the evidence to date;Expert Opinion on Drug Discovery;2022-07-28

4. Synthesis of Benzalacetophenone-based Isoxazoline and Isoxazole Derivatives;Current Organic Chemistry;2022-04

5. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents;Bioorganic & Medicinal Chemistry;2022-01